US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NETLease Corporate Real Estate ETF

26.20

-0.0285-0.11%

Post-market: 26.200.00000.00%19:52 EDT

Volume:18.08K

Turnover:474.79K

Market Cap:55.02M

PE:- -

High:26.41

Open:26.25

Low:26.19

Close:26.23

52wk High:28.43

52wk Low:23.56

Shares:2.10M

Float Shares:2.10M

Volume Ratio:2.28

T/O Rate:0.86%

Dividend:1.25

Dividend Rate:4.79%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Real Estate Companies: NNN REIT (NNN) and Realty Income (O)

VICI Properties Announces New Senior Notes Offering

Urban Edge Q2 FFO Per Share Rises on New Leases, Lifts 2026 Outlook

CareTrust REIT Q2 Net Income Slightly Beats, Raises 2026 Outlook

Clipper Realty Q2 Revenue Falls on Lower Commercial Rents

Press Release: OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights

Press Release: NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results

Wall Street Analysts Are Bullish on Top Real Estate Picks

Whitehawk’s HWK-016 ADC Trial Advances in Tough Ovarian and Endometrial Cancers

Analysts Offer Insights on Real Estate Companies: First Industrial Realty (FR), Host Hotels & Resorts (HST) and Realty Income (O)

Is Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Cheap As ADC Pipeline News Builds?

Simply Wall St.

Marcus & Millichap ‘remains well-positioned’ to return to long-term growth

Press Release: Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

FrontView REIT Q2 Adjusted FFO Per Share Rises

Analysts Conflicted on These Real Estate Names: NNN REIT (NNN), Chimera Investment (CIM) and Opendoor Technologies (OPEN)

Press Release: Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates

Hong Kong Stock Moves: SKB BIO Surges Over 4% Before Noon as New Dual-Load ADC Drug Gets Clinical Trial Approval

Realty Income Corporation Reports Results for the Quarter Ended June 30 - Earnings Summary

Gladstone Commercial Q2 Revenue Rises 5%, Beats Estimates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/NETL/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NETL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NETL\",,,,,undefined,":{"symbol":"NETL","market":"US","secType":"STK","nameCN":"NETLease Corporate Real Estate ETF","latestPrice":26.2,"timestamp":1788552000000,"preClose":26.2285,"halted":0,"volume":18083,"hourTrading":{"tag":"盘后","latestPrice":26.2,"preClose":26.2,"latestTime":"19:52 EDT","volume":233,"amount":6131.6,"timestamp":1788565932519,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.001086604266351529,"floatShares":2100000,"shares":2100000,"eps":0,"marketStatus":"Market Closed","change":-0.0285,"latestTime":"09-04 16:00:00 EDT","open":26.25,"high":26.41,"low":26.185,"amount":474790.629521,"amplitude":0.008578,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":26.2285,"sharesOutstanding":1775000,"nav":26.23,"aum":55083000,"dividendRate":0.047859,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":26.2,"preClose":26.2,"latestTime":"19:52 EDT","volume":233,"amount":6131.6,"timestamp":1788565932519,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.276595707420692,"impliedVol":0.0576,"impliedVolPercentile":0.0397},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NETL\",,,,,undefined,":{"symbol":"NETL","floatShares":2100000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.276595707420692,"shares":2100000,"dividePrice":1.2539,"high":26.41,"amplitude":0.008578,"preClose":26.2285,"low":26.185,"week52Low":23.56,"pbRate":"--","week52High":28.4299,"institutionHeld":0,"latestPrice":26.2,"eps":0,"divideRate":0.047859,"volume":18083,"delay":0,"ttmEps":0,"open":26.25,"prevYearClose":23.727,"prevWeekClose":26.3429,"prevMonthClose":26.1278,"prevQuarterClose":26.7001,"fiveDayClose":26.3429,"twentyDayClose":26.82,"sixtyDayClose":26.8572},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NETL\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"NETL","amount":0.105,"announcedDate":"2026-08-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-27","defaultRemindTime":1787837400000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-31","payableDate":"2026-08-27","currency":"USD","dateTimestamp":1787803200000,"payDate":"2026-08-31"},{"date":"2026-07-29","symbol":"NETL","amount":0.105,"announcedDate":"2026-07-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-29","defaultRemindTime":1785331800000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-31","payableDate":"2026-07-29","currency":"USD","dateTimestamp":1785297600000,"payDate":"2026-07-31"},{"date":"2026-06-26","symbol":"NETL","amount":0.105,"announcedDate":"2026-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-26","defaultRemindTime":1782480600000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-26","currency":"USD","dateTimestamp":1782446400000,"payDate":"2026-06-30"},{"date":"2026-05-27","symbol":"NETL","amount":0.105,"announcedDate":"2026-05-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-27","defaultRemindTime":1779888600000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-29","payableDate":"2026-05-27","currency":"USD","dateTimestamp":1779854400000,"payDate":"2026-05-29"},{"date":"2026-04-28","symbol":"NETL","amount":0.105,"announcedDate":"2026-04-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-28","defaultRemindTime":1777383000000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-30","payableDate":"2026-04-28","currency":"USD","dateTimestamp":1777348800000,"payDate":"2026-04-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NETL\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-30","recordDate":"2019-12-31","paymentDate":"2020-01-02","value":0.031935,"currency":"USD"},{"executeDate":"2020-03-17","recordDate":"2020-03-18","paymentDate":"2020-03-19","value":0.0097783,"currency":"USD"},{"executeDate":"2020-03-31","recordDate":"2020-04-01","paymentDate":"2020-04-02","value":0.1912399,"currency":"USD"},{"executeDate":"2020-06-26","recordDate":"2020-06-29","paymentDate":"2020-06-30","value":0.2782635,"currency":"USD"},{"executeDate":"2020-09-15","recordDate":"2020-09-16","paymentDate":"2020-09-30","value":0.2792338,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NETL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NETL\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657160526","title":"Analysts Offer Insights on Real Estate Companies: NNN REIT (NNN) and Realty Income (O)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657160526","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657160526?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:01","pubTimestamp":1786093281,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Real Estate sector with new ratings on NNN REIT (NNN) and Realty Income (O). NNN REIT (NNN) In a report...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-nnn-reit-nnn-and-realty-income-o-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-nnn-reit-nnn-and-realty-income-o-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLIM","LU0192582467.USD","LU0348788117.USD","LU0455707207.USD","MDIV","LU0871576103.HKD","LU1981816686.USD","IE0003851619.USD","LU0054237671.USD","LU0868486357.SGD","LU0589944569.HKD","LU0320764599.SGD","LU0181495838.USD","IE00B0169L03.USD","LU0188438112.USD","LU0588545490.SGD","DFRA","IE0003795394.USD","LU0672654166.SGD","BK4588","REIT","LU0052750758.USD","PSCF","SG9999002828.SGD","YLDW","LU0823413660.USD","RWR","LU2242644610.SGD","RJMG","NETL","RNTY","IQRA","LU1831875114.USD","DFAR","NNN","LU0164872284.USD","TSRS","LU0650527681.SGD","IE00B29SXG58.USD","BPRE","IVRA","LU0163747925.USD","LU0164865239.USD","LU1224709979.USD","O","ERET","SRHR","LU0211977185.USD","DPRE","LU0878004406.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657666985","title":"VICI Properties Announces New Senior Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2657666985","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657666985?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:34","pubTimestamp":1786052044,"startTime":"0","endTime":"0","summary":"The latest announcement is out from VICI Properties ( ($VICI) ). On August 5, 2026, VICI Properties L.P. entered an underwriting agreement to issue...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vici-properties-announces-new-senior-notes-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vici-properties-announces-new-senior-notes-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4084","TSRS","VICI","BK4588","NETL","GQRE","BK4561","BK4234"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657663822","title":"Urban Edge Q2 FFO Per Share Rises on New Leases, Lifts 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657663822","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657663822?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:42","pubTimestamp":1786048965,"startTime":"0","endTime":"0","summary":"Urban Edge Q2 FFO per share rises on new leases, lifts 2026 outlookOverviewU.S. retail real estate REIT's Q2 FFO per share rose yr/yr, driven by new lease commencementsQ2 net income and EPS declined y","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KIM","SRHR","UE","DFAR","RWR","CLIM","O","DPRE","BK4588","NETL","TSRS","BK4585","ERET","BK4080","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657123668","title":"CareTrust REIT Q2 Net Income Slightly Beats, Raises 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657123668","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657123668?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:34","pubTimestamp":1786048485,"startTime":"0","endTime":"0","summary":"CareTrust REIT Q2 net income slightly beats, raises 2026 outlookOverviewUS healthcare REIT's Q2 net income rose 9% yr/yr, slightly beating analyst expectationsNormalized FFO per share grew 19% yr/yr t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431J7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0054450605.USD","LU0229945570.USD","LU0049853897.USD","LU0320764755.SGD","LU0345775950.USD","LU0106252389.USD","LU0287142896.SGD","SRHR","LU0315178854.USD","LU0455707207.USD","LU0181495838.USD","KBWY","LU0048580855.USD","LU0048597586.USD","IE0008369823.USD","LU0819121731.USD","NETL","LU0164865239.USD","LU0607220059.USD","LU1981816686.USD","LU0140636845.USD","LU0128522744.USD","LU0588545904.SGD","LU0594300419.USD","IE00B8L5B284.USD","LU0164872284.USD","LU0307460666.USD","LU0856984785.SGD","CHCT","RSPR","LU0449509016.USD","LU0868486357.SGD","LU0149534421.HKD","CTRE","LU0165289439.USD","LU0449515922.USD","DOC","LU0672654166.SGD","LU1224709979.USD","LU0029874905.USD","LU0054237671.USD","LU0605514214.HKD","LU1769817096.USD","LU0708995153.HKD","LU0823426308.USD","TSRS","LU0370786039.SGD","LU0871576103.HKD","LU0828237940.HKD","NNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657865006","title":"Clipper Realty Q2 Revenue Falls on Lower Commercial Rents","url":"https://stock-news.laohu8.com/highlight/detail?id=2657865006","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657865006?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:24","pubTimestamp":1786047842,"startTime":"0","endTime":"0","summary":"Clipper Realty Q2 revenue falls on lower commercial rentsOverviewUS multifamily and commercial landlord's Q2 revenue declined yr/yr on lower commercial rentsQ2 net loss widened, mainly reflecting NYC ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431E9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFAR","DESK","BK4215","NETL","BK4588","DPRE","BK4080","RWR","BK4194","CLIM","BK4231","CLPR","TSRS","BK4585","ERET","SRHR","BK4223","VNO","O","DEI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657579126","title":"Press Release: OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2657579126","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657579126?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:05","pubTimestamp":1786046700,"startTime":"0","endTime":"0","summary":"Raises Full Year 2026 Revenue and Cash Outlook Driven by Continued Business MomentumConference Call to Begin Today at 4:30 p.m. ETEMERYVILLE, Calif.--(BUSINESS WIRE)--August 06, 2026--OmniAb, Inc. (NA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","R","NETL","OABI","BK4121","ADC","BK4022","BK4232","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657520016","title":"Press Release: NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657520016","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657520016?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046460,"startTime":"0","endTime":"0","summary":"-- Preserving Capital in Support of Merger Closing; Continuing Clinical. all-stock transaction. Upon closing, the combined company is expected to. operate as Avere Therapeutics and trade on Nasdaq under the ticker symbol. \"AVRX\". Existing NextCure stockholders are expected to receive contingent. value rights  tied to certain legacy NextCure assets.Concurrently, Avere Therapeutics entered into a securities purchase. agreement providing for a private financing expected to generate. approximately $320 million in gross proceeds immediately prior to closing. of the merger, subject to customary closing conditions.-- Entered into a Transition and Continuation Agreement with LigaChem. Biosciences  under which LigaChem has elected to continue the. development of LNCB74 as the \"Sole Developing Party\" pursuant to the. terms under the parties' November 2022 Research Collaboration and. remains eligible to receive future milestone and royalty payments for the. including facility footprint reductions","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NETL","BK4139","BK4080","NXTC","ADC","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656756","title":"Wall Street Analysts Are Bullish on Top Real Estate Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656756","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656756?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:50","pubTimestamp":1786035020,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on Realty Income (O) and Iron Mountain (IRM) with bull...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-real-estate-picks-blurbs-news-33?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-real-estate-picks-blurbs-news-33?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SRHR","SRVR","BK4080","NETL","BK4234","DFAR","BK4231","DPRE","O","BK4084","REAI","BK4585","CLIM","TSRS","RWR","ERET","BK4588","IRM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656921","title":"Whitehawk’s HWK-016 ADC Trial Advances in Tough Ovarian and Endometrial Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656921?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:36","pubTimestamp":1786034167,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics, Inc. ($WHWK) announced an update on their ongoing clinical study. Whitehawk Therapeutics, Inc. is running a Phase 1, first-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/whitehawks-hwk-016-adc-trial-advances-in-tough-ovarian-and-endometrial-cancers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/whitehawks-hwk-016-adc-trial-advances-in-tough-ovarian-and-endometrial-cancers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NETL","BK4080","ADC","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657744658","title":"Analysts Offer Insights on Real Estate Companies: First Industrial Realty (FR), Host Hotels & Resorts (HST) and Realty Income (O)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657744658","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657744658?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:02","pubTimestamp":1786028521,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Real Estate sector with new ratings on First Industrial Realty (FR), Host Hotels & Resorts (HST) and Re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-first-industrial-realty-fr-host-hotels-resorts-hst-and-realty-income-o-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-first-industrial-realty-fr-host-hotels-resorts-hst-and-realty-income-o-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SRHR","BK4224","BK4181","BK4585","O","BK4171","HST","CLIM","FR","BK4080","BK4588","DFAR","BK4218","BK4231","RWR","ERET","NETL","TSRS","SLVP","DPRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657659724","title":"Is Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Cheap As ADC Pipeline News Builds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2657659724","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657659724?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:37","pubTimestamp":1786023454,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) is back in focus after Chinese regulators accepted a new indication application for its TROP2-directed ADC sacituzumab tirumotecan in first-line triple-negative breast cancer.\nSee our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical.\nThe regulatory momentum around sacituzumab tirumotecan and SKB565 comes alongside a 26.81% year to date share price return and a very large 3 year total shareholder return of about 7x. This suggests...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/is-sichuan-kelun-biotech-biopharmaceutical-sehk6990-cheap-as","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/is-sichuan-kelun-biotech-biopharmaceutical-sehk6990-cheap-as","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NETL","BK4080","BK4581","BK4231","BK4588","ADC","LU0196878994.USD","BK4585","06990","XBI","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657639423","title":"Marcus & Millichap ‘remains well-positioned’ to return to long-term growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2657639423","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657639423?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:10","pubTimestamp":1786018246,"startTime":"0","endTime":"0","summary":"The company said, “Despite ongoing price discovery and wider than normal bid/ask spreads, the Company believes the commercial real estate transacti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/marcus-millichap-remains-well-positioned-to-return-to-long-term-growth-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/marcus-millichap-remains-well-positioned-to-return-to-long-term-growth-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NETL","FLV","KBWD","IWS","KRE","DFNL","FRI","PFFR","PPTY","HYIN","JRE","MDIV","NURE","JPRE","IRET","FXO","HAUZ","IWN","CSRE","DFGR","MMI","FTXO","FPRO","INDS","DESK","BBRE","IYRI","REET","GMOV","DFAR","BLDG","KBWB","ALTY","JPO","INKM","ITAN","PFI","GRI","KBWY","BYRE","GABF","AVRE","FREL","GQRE","HIPS","ICF","IFGL","AREA","IQRA","CRED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657636277","title":"Press Release: Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2657636277","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657636277?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:00","pubTimestamp":1786017600,"startTime":"0","endTime":"0","summary":"financing. The financing included participation from existing investors. including Avoro Capital, QVT, Coastlands Capital, KVP Capital, ADAR1. Capital Management, Acuta Capital Partners, StemPoint Capital LP, Invus,as well as members of Whitehawk's executive team.-- Continued to enroll patients into ongoing Phase 1 trials for HWK-007 and. -- HWK--007 is being evaluated in patients with non-squamous, EGFR. cancer; and endometrial cancer . The study design was. presented as a Trials-in-Progress poster at the American Society. -- Entered into a new option agreement with Hangzhou DAC for access to. CPT113 for use in up to five additional ADC programs. Whitehawk's ADC. platform leverages CPT113 as the core linker-payload technology, adding. bioconjugation process to support improved stability and therapeutic","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4007","IND","LENZ","BK4080","ADC","WHWK","R","BK4231","BK4139","BK4539","NETL","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657634536","title":"ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657634536","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657634536?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:00","pubTimestamp":1786017600,"startTime":"0","endTime":"0","summary":"– On track for mid-2027 topline data readout from 80 patients in the Phase 2 ASPEN-09-Breast clinical trial evaluating evorpacept in combination with trastuzumab and chemotherapy in HER2-positive meta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/06/3340196/0/en/ALX-Oncology-Reports-Second-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NETL","BK4080","BK4231","ADC","ALX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657039633","title":"FrontView REIT Q2 Adjusted FFO Per Share Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2657039633","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657039633?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:31","pubTimestamp":1786015881,"startTime":"0","endTime":"0","summary":"FrontView REIT Q2 adjusted FFO per share risesOverviewU.S. net-lease REIT's Q2 Adjusted FFO per share rose to $0.33 from $0.32 yr/yrCompany raised 2026 AFFO per share and net investment guidanceOutloo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4430K5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWY","LU0173614495.USD","RWR","LU0052750758.USD","LU0708995583.HKD","LU0828237940.HKD","LU0307460666.USD","LU0370786039.SGD","LU0192582467.USD","LU0708995153.HKD","LU1770036033.HKD","TSRS","DFAR","LU0164865239.USD","LU0164872284.USD","LU0589944569.HKD","ERET","LU0048597586.USD","LU0594300179.USD","NETL","LU0320764599.SGD","LU0823426480.USD","LU0588546209.SGD","IE00B8HQ1Z84.USD","FVR","LU0819121731.USD","LU0650527681.SGD","LU0823426308.USD","LU0320764243.SGD","LU1981816686.USD","LU0029875118.USD","DPRE","LU0431992006.USD","LU1048596156.SGD","LU0345775950.USD","O","LU0821914370.USD","NNN","LU0128522157.USD","GOOD","CLIM","LU0823413660.USD","LU0211977185.USD","LU0054237671.USD","LU0261950983.USD","LU0043850808.USD","SRHR","LU0163747925.USD","LU0823397285.USD","LU0878004406.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638818","title":"Analysts Conflicted on These Real Estate Names: NNN REIT (NNN), Chimera Investment (CIM) and Opendoor Technologies (OPEN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638818","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638818?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:01","pubTimestamp":1786014101,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Real Estate sector with new ratings on NNN REIT (NNN), Chimera Investment (CIM) and Opendoor Technologi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-real-estate-names-nnn-reit-nnn-chimera-investment-cim-and-opendoor-technologies-open-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-real-estate-names-nnn-reit-nnn-chimera-investment-cim-and-opendoor-technologies-open-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0214875030.USD","LU0228367735.SGD","OPEG","BK4561","LU0823413587.USD","LU0287142896.SGD","LU0605514214.HKD","LU0164872284.USD","BK4080","OPEN","LU0594300179.USD","LU0132412106.USD","LU0029875118.USD","LU1956131251.USD","LU0043850808.USD","LU0345775950.USD","LU1831875114.USD","LU2242644610.SGD","LU0823426308.USD","LU0823397285.USD","IE0008369823.USD","LU1224709979.USD","LU0261950983.USD","LU0164865239.USD","LU0543330483.HKD","NETL","LU0878004406.USD","BK4079","LU1770036033.HKD","SG9999002828.SGD","LU0828237940.HKD","LU0048580855.USD","LU0737861699.HKD","IE00B0169L03.USD","LU0251144936.SGD","IE0003795394.USD","LU0589944569.HKD","LU0261947096.USD","LU0106259558.USD","LU0650527681.SGD","LU0856984785.SGD","LU0052750758.USD","LU1048596156.SGD","LU0128522744.USD","LU0607220059.USD","LU0868486357.SGD","LU1981816686.USD","LU0211977185.USD","LU0054450605.USD","LU0708995153.HKD","LU0348788117.USD","LU0165289439.USD","LU0449515922.USD","LU0588545490.SGD","LU0871576103.HKD","LU0823413660.USD","LU0054237671.USD","IE00B8HQ1Z84.USD","LU0431992006.USD","LU0231483743.USD","LU0149534421.HKD","LU0594300419.USD","LU0823426480.USD","LU0593848301.USD","LU0229945570.USD","LU0188438112.USD","NNN","LU0502904849.HKD","LU0259732245.USD","LU0821914370.USD","BK4231","LU0307460666.USD","LU0181495838.USD","BK4110","LU0163747925.USD","LU0128522157.USD","CIM","LU0048597586.USD","LU0029874905.USD","LU0708995583.HKD","LU0672654166.SGD","LU0588546209.SGD","LU0328353924.USD","LU0320764755.SGD","LU0140636845.USD","LU0049853897.USD","LU0320764599.SGD","LU0106252389.USD","LU0320764243.SGD","LU0588545730.USD","TSRS","LU0048388663.USD","IE00B8L5B284.USD","IE00B29SXG58.USD","BK4562","LU0370786039.SGD","LU0449509016.USD","LU0890818403.SGD","LU0865486749.SGD","LU1769817096.USD","LU0455707207.USD","LU0543330566.HKD","IE0003851619.USD","LU0315178854.USD","LU0862451753.SGD","LU0173614495.USD","OPEX","LU0588545904.SGD","LU0819121731.USD","LU0192582467.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657687386","title":"Press Release: Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657687386","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657687386?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:30","pubTimestamp":1786012200,"startTime":"0","endTime":"0","summary":"--  The Company advanced multiple global oncology and immunology programs. toward key clinical and regulatory milestones, with significant pipeline. --  Global Phase 1 data for zocilurtatug pelitecan  in combination. with a PD-L1 inhibitor in first-line SCLC to be presented at ESMO 2026;planned initiation of a registrational Phase 3 study later this year. --  Registrational Phase 3 DLLEVATE study evaluating zoci in second-line. plus SCLC remains on track, with enrollment expected to be completed in. the first half of 2027, supporting a potential U.S. accelerated approval. --  Global Phase 1/1b study of ZL-1503, a potential first-in-class. long-acting IL-13/IL-31R<ALPHA> bispecific antibody for the treatment of. atopic dermatitis, continues to advance, with initial first-in-human data. --  KarXT successfully launched in mainland China; encouraging early launch. trends building momentum ahead of potential NRDL inclusion. --  Total revenues of $106.3 million in the second quarter of 2026;","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4080","BK4526","IE0009354923.USD","BK4231","BK4081","EMA","ADC","BK4548","BK4139","ZLAB","BK4232","ODD","BK4022","NETL","BK4531","BK4585","IND","R","BK4588","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182119210","title":"Hong Kong Stock Moves: SKB BIO Surges Over 4% Before Noon as New Dual-Load ADC Drug Gets Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1182119210","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182119210?lang=en_us&edition=fundamental","pubTime":"2026-08-06 11:22","pubTimestamp":1785986533,"startTime":"0","endTime":"0","summary":"SKB BIO (06990) climbed more than 4% before the midday trading session, with shares last up 3.8% to HK$510.5, on turnover of HK$95.924 million.The company recently announced that it has received a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDTX","BK4231","IBBQ","KCAI","LU0196878994.USD","NETL","VXUS","BK1161","IBBJ","ADC","BK4585","BMED","PSYK","BK4080","06990","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657257162","title":"Realty Income Corporation Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657257162","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657257162?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:56","pubTimestamp":1785966986,"startTime":"0","endTime":"0","summary":"Realty Income Corporation reports results for the quarter ended June 30 - Earnings SummaryRealty Income CorporationO.Nreported quarterly adjusted earnings of 37 cents per share for the quarter ended J","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4423OK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DPRE","SRHR","RWR","O","DFAR","BK4231","CLIM","ERET","TSRS","BK4585","BK4588","NETL","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657157951","title":"Gladstone Commercial Q2 Revenue Rises 5%, Beats Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657157951","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657157951?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:20","pubTimestamp":1785964855,"startTime":"0","endTime":"0","summary":"Gladstone Commercial Q2 revenue rises 5%, beats estimatesOverviewUS real estate investment trust's Q2 operating revenue rose 5%, beating analyst expectationsCore FFO per share rose 8.6% to $0.38, driv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421JO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0149534421.HKD","LU0543330483.HKD","LU0173614495.USD","KBWY","LU0672654166.SGD","LU0431992006.USD","LU0828237940.HKD","LU0214875030.USD","LU1831875114.USD","LU0594300419.USD","LU0029875118.USD","LU0823426480.USD","SG9999002828.SGD","LU0868486357.SGD","LU0345775950.USD","LU0823397285.USD","GOOD","BK4231","LU0140636845.USD","LU0163747925.USD","BK4160","LU2242644610.SGD","DEA","LU0164872284.USD","NETL","LU0605514214.HKD","LU0708995153.HKD","CLIM","LU0259732245.USD","LU0370786039.SGD","LU0650527681.SGD","SRHR","LU0823413660.USD","DPRE","RWR","IE00B8L5B284.USD","LU0449515922.USD","ERET","LU0043850808.USD","TSRS","LU0708995583.HKD","LU1981816686.USD","LU0589944569.HKD","O","NNN","LU0588545730.USD","LU0029874905.USD","LU0819121731.USD","DFAR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}